mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.03 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |